Evoke Pharma 8-K Shows Co. Submitted Response To FDA's Multi-Disciplinary Review Letter Related To Gimoti 505 New Drug Application; Co. Requested FDA Meeting Prior To Apr. 1, 2019 PDUFA Date
Benzinga Newsdesk